Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Melinda Durr

Partner, Health & Life Sciences, Oliver Wyman

Here’s more on how proposed modifications to CMS’ Advance Notice Summary may affect reimbursement, payment growth rates, and regulation.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

Details on the final Call Letter and advice for where plans should place their strategic focus in 2018.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

With the Medicare Advantage opportunity large and growing, many provider organizations are convinced that they, too, want to be a part of the risk equation.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman

Access here our full series examining the increasing role providers are playing in government programs and risk management.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

More and more, we are seeing health systems and physician groups move up the value chain and become risk managers, rather than volume-drivers.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Insights in your inbox

Subscribe

CMS Star Ratings are do-or-die for health plans. And this year, the bar is higher than ever. Our latest analysis finds that a health plan’s Star rating is defined primarily by the behavior of its providers.

Associate, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman